1 Min Read
June 26 (Reuters) - Bayer AG
* Says receives approval for Stivarga in Japan for second-line treatment of hepatocellular carcinoma Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.